| |
| |
|
| Insider
Information: |
Kjellson Nina S |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,983,884 |
|
|
Indirect Shares
|
8,226,509 |
|
|
| Direct
Value |
$4,424,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,210,393 |
|
|
| Total
Value |
$4,424,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
Director, 10% Owner |
2010-08-06 |
0 |
2010-08-06 |
3,548,643 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2011-09-21 |
1,983,884 |
2011-09-21 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2013-11-08 |
1,248,064 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Director |
2015-04-20 |
0 |
2015-04-20 |
1,356,813 |
Premium* |
|
|
Celladon Corp |
CLDN |
Director, 10% Owner |
|
0 |
2016-03-22 |
1,599,593 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
Director |
2021-09-17 |
0 |
2021-09-17 |
473,396 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TYRA |
Tyra Biosciences, Inc. |
Director |
– • – |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
4,409,991 |
473,396 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-12-11 |
4 |
D |
$1.52 |
$19,000 |
D/D |
(12,500) |
0 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| CLDN |
Celladon Corp |
Director |
– • • |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,599,593 |
|
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Director |
– • – |
2015-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,156,813 |
1,356,813 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Director |
– • – |
2015-04-20 |
4 |
B |
$16.00 |
$3,200,000 |
I/I |
200,000 |
200,000 |
2.1 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2013-11-08 |
4 |
B |
$0.00 |
$0 |
I/I |
422,238 |
1,248,064 |
2.02 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2013-07-15 |
4 |
B |
$6.03 |
$2,600,000 |
I/I |
431,435 |
825,826 |
2.1 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2013-07-15 |
4 |
A |
$0.00 |
$0 |
I/I |
394,391 |
394,391 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2011-09-21 |
4 |
B |
$7.24 |
$1,573,122 |
D/D |
217,228 |
1,983,884 |
2.45 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2011-09-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,766,656 |
|
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • • |
2010-08-06 |
4 |
B |
$5.00 |
$6,136,665 |
I/I |
1,227,333 |
3,548,643 |
2.25 |
- |
|
| TSRX |
Trius Therapeutics Inc |
Director |
– • • |
2010-08-06 |
4 |
A |
$0.00 |
$3,260,892 |
I/I |
2,321,310 |
2,321,310 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
